Ouabain induces apoptosis on PHA-activated lymphocytes

Biosci Rep. 1998 Feb;18(1):1-7. doi: 10.1023/a:1022259832207.

Abstract

Apoptotic cell death plays a critical role in immune system homeostasis, and c-myc protooncogene deregulated expression is a component of this programmed genomic response. Pharmacological intervention and modulation of peripheral lymphocytes apoptosis would have important implications. The present results indicate that ouabain, a specific inhibitor of Na+K(+)-ATPase, promotes an increased expression of c-myc mRNA, and induces apoptosis in PHA-stimulated lymphocytes. Furthermore, this ouabain-induced apoptosis cannot be counteracted by the addition of exogenous IL-2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis*
  • Cell Division
  • Cytoplasm / metabolism
  • DNA Fragmentation
  • Enzyme Inhibitors / pharmacology
  • Gene Expression
  • Humans
  • Lymphocyte Activation*
  • Lymphocytes / cytology
  • Lymphocytes / drug effects*
  • Lymphocytes / metabolism
  • Ouabain / pharmacology*
  • Phytohemagglutinins / pharmacology
  • Proto-Oncogene Proteins c-myc / biosynthesis*
  • Proto-Oncogene Proteins c-myc / genetics
  • RNA, Messenger

Substances

  • Enzyme Inhibitors
  • Phytohemagglutinins
  • Proto-Oncogene Proteins c-myc
  • RNA, Messenger
  • Ouabain